# Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

> **NCT01765452** · PHASE4 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 285 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Closone
- **DRUG:** Plavix with Astrix

## Key facts

- **NCT ID:** NCT01765452
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765452, "Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01765452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*